Skip to main content

Advertisement

SpringerLink
Log in

Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

To investigate the incidence and the associated factors for bone metastases (BM) development and prognosis in initial colorectal cancer (CRC) with a large sample using Surveillance, Epidemiology, and End Results (SEER) cohort.

Methods

Primary CRC patients, who were initially diagnosed between 2010 and 2015 in the SEER database, were included to analyze BM incidence and risk factors for BM occurrence. The patients with at least 1-year follow-up were involved to investigate the prognostic factors for BM. Multivariable logistic and proportional hazard regression models were used to investigate the risk factors for BM development and prognosis, respectively.

Results

A total of 212,787 eligible CRC patients were included and 2557 of them were diagnosed with de novo BM (1.20%). Rectal cancer presented significantly higher BM incidence than right and left colon cancer (χ2 = 107.64, P < 0.001). T1 stage, poor differentiated grade, and brain metastases were homogeneously associated factors for BM development and BM patients’ survival. Male gender, higher N stage, rectal site, elevated carcinoembryonic antigen, and lung and liver metastases were positively associated with BM occurrence. Older age, unmarried status, right colon site, and non-surgery were found to positively correlate with the death risk of CRC patients with BM.

Conclusions

BM is rare in CRC patients. Homogeneous and heterogeneous factors were found for BM development and BM patients’ survival. The risk factors and prognostic factors can be used for BM screening and patient’s prognosis estimation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Reference

  1. Lyon France: International Agency for Research on Cancer (2013). Available at http://www.globocan.iarc.fr. Accessed 6th July 2018

  2. Roth ES, Fetzer DT, Barron BJ, Joseph UA, Gayed IW, Wan DQ (2009) Does colon cancer ever metastasize to bone first? A temporal analysis of colorectal cancer progression. BMC Cancer 9:274

  3. Van Cutsem E, Oliveira J (2009) Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl):461–463

    Google Scholar 

  4. Baek SJ, Hur H, Min BS, Baik SH, Lee KY, Kim NK (2016) The characteristics of bone metastasis in patients with colorectal cancer: a long-term report from a single institution. World J Surg 40(4):982–986

    Article  PubMed  Google Scholar 

  5. Zhenghong, Zihua Z, Guoweijian, Zhangning, Caiyunyun, Yingjiangshan et al (2017) Retrospective study of predictors of bone metastasis in colorectal cancer patients. J Bone Oncol 9:25–28

  6. Abdel-Rahman O (2018) Predictors of skeletal-related events among cancer patients with bone metastases treated with zoledronic acid: a secondary analysis of a randomized study. Expert Opin Drug Saf 17(8):757–761

    Article  CAS  PubMed  Google Scholar 

  7. Hage WD, Aboulafia AJ, Aboulafia DM (2000) Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin North Am 31(4):515–528

    Article  CAS  PubMed  Google Scholar 

  8. Guo X, Zhang C, Guo Q, Xu Y, Feng G, Li L et al (2018) The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer. Cancer Manag Res 10:1639–1646

  9. Khattak MA, Martin HL, Beeke C, Price T, Carruthers S, Kim S et al (2012) Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from south Australian clinical registry for advanced colorectal cancer. Clin Colorectal Cancer 11(4):247–254

    Article  PubMed  Google Scholar 

  10. Kawamura H, Yamaguchi T, Yano Y, Hozumi T, Takaki Y, Matsumoto H et al (2018) Characteristics and prognostic factors of bone metastasis in patients with colorectal cancer. Dis Colon Rectum 61(6):673–678

    PubMed  Google Scholar 

  11. Cassidy J, Saltz LB, Giantonio BJ, Kabbinavar FF, Hurwitz HI, Rohr UP (2010) Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies. J Cancer Res Clin Oncol 136(5):737–743

    Article  CAS  PubMed  Google Scholar 

  12. Portales F, Thezenas S, Samalin E, Assenat E, Mazard T, Ychou M (2015) Bone metastases in gastrointestinal cancer. Clin Exp Metastasis 32(1):7–14

    Article  CAS  PubMed  Google Scholar 

  13. Li A, Tan Z, Fu C, Wang H, Yuan J (2017) Analysis of risk factors for bone metastasis after radical resection of colorectal cancer within 5 years. Zhonghua Wei Chang Wai Ke Za Zhi 20(1):58–61

    PubMed  Google Scholar 

  14. Sun C, Deng Y, Zhou H, Hu ZQ (2015) Risk factors for the development of metachronous bone metastasis in colorectal cancer patients after curative resection. Int J Surg 21:145–149

  15. Liu F, Zhao J, Xie J, Xie L, Zhu J, Cai S, Zheng H, Xu Y (2016) Prognostic risk factors in patients with bone metastasis from colorectal cancer. In: Tumour Biol, vol 37, pp 16127–16134

    Google Scholar 

  16. Heras P, Karagiannis S, Kritikos K, Hatzopoulos A, Mitsibounas D (2007) Ibandronate is effective in preventing skeletal events in patients with bone metastases from colorectal cancer. Eur J Cancer Care (Engl) 16(6):539–542

    Article  CAS  Google Scholar 

  17. Zhang Y, Guo X, Wang G, Ma W, Liu R, Han X et al (2018) Real-world study of the incidence, risk factors, and prognostic factors associated with bone metastases in women with uterine cervical cancer using Surveillance, Epidemiology, and End Results (SEER) data analysis. Med Sci Monit 24:6387–6397

  18. Xiong Z, Deng G, Huang X, Li X, Xie X, Wang J et al (2018) Bone metastasis pattern in initial metastatic breast cancer: a population-based study. Cancer Manag Res 10:287–295

  19. Santini D, Tampellini M, Vincenzi B, Ibrahim T, Ortega C, Virzi V, Silvestris N, Berardi R, Masini C, Calipari N, Ottaviani D, Catalano V, Badalamenti G, Giannicola R, Fabbri F, Venditti O, Fratto ME, Mazzara C, Latiano TP, Bertolini F, Petrelli F, Ottone A, Caroti C, Salvatore L, Falcone A, Giordani P, Addeo R, Aglietta M, Cascinu S, Barni S, Maiello E, Tonini G (2012) Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol 23(8):2072–2077

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The present study was sponsored by the Natural Science Foundation of China (81702161, 81872184, 81801781, and 81602363), the grant of Russian Foundation of Basic Research (15–29-01338), Natural Science Foundation of Tianjin Science and Technology Committee China (17JCQNJC11000), Natural Science Foundation of Tianjin Medical University (2016KYZQ10), and The Doctor Start-up Grant of Tianjin Medical University Cancer Institute and Hospital [B1612, B1711].

Author information

Author notes

  1. Xu Guo, Chao Zhang and Wenjuan Ma contributed equally to this work.

Authors and Affiliations

  1. Department of Bone and Soft Tissue Tumors, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Huanhu Xi Road, Tiyuan Bei, Hexi District, Tianjin, 300060, China

    Xu Guo, Chao Zhang, Guijun Xu, Xiuxin Han, Guowen Wang & Yulin Ma

  2. Department of Orthopedics, Cangzhou Central Hospital, Cangzhou, Hebei, China

    Xu Guo

  3. Department of Breast Imaging, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

    Wenjuan Ma

  4. Department of colorectal cancer, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

    Fei Tian

  5. Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University Harbin, China, Harbin, China

    Peng Sun

  6. Department of Colorectal Surgery, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Peng Sun

  7. Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Biomedical Agency of the Russian Federation, Moscow, Russian Federation

    Vladimir P. Baklaushev & Andrey S. Bryukhovetskiy

  8. Department of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University, 30 Gaotanyan Street Shapingba District, Chongqing, 400038, China

    Xin Wang

Authors
  1. Xu Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenjuan Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fei Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guijun Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiuxin Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Peng Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Vladimir P. Baklaushev
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Andrey S. Bryukhovetskiy
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Guowen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yulin Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Xin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yulin Ma or Xin Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The present study complied with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards and the study was approved by the Research Ethics Board of the Tianjin Medical University Cancer Institute and Hospital.

Informed consent

The SEER database is an open public database, and the release of data from the SEER database does not require informed patient consent because cancer is a reportable disease in every state of the USA.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, X., Zhang, C., Ma, W. et al. Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database. Int J Colorectal Dis 34, 533–543 (2019). https://doi.org/10.1007/s00384-018-3213-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-018-3213-5

Keywords

Search

Navigation